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Carbon Dioxide (CO2) removal is one of the primary functions of the International Space Station (ISS) 
atmosphere revitalization systems.  Primary CO2 removal is via the ISS’s two Carbon Dioxide Removal 
Assemblies (CDRAs) and the Russian Carbon Dioxide removal assembly (Vozdukh); both of these systems 
are regenerable, meaning that their CO2 removal capacity theoretically remains constant as long as the 
system is operating. Contingency CO2 removal capability is provided by Lithium Hydroxide (LiOH) 
canisters, which are consumable, meaning that their CO2 removal capability disappears once the resource is 
used.  
 
With the advent of 6 crew ISS operations, experience showing that CDRA failures are not uncommon, and 
anecdotal association of crew symptoms with CO2 values just above 4 mmHg, the question arises: How much 
lower do we keep CO2 levels to minimize the risk to crew health and performance, and what will the 
operational cost to the CDRAs be to do it? The primary crew health concerns center on the interaction of 
increased intracranial pressure from fluid shifts and the increased intracranial blood flow induced by CO2. 
Typical acute symptoms include headache, minor visual disturbances, and subtle behavioral changes. The 
historical database of CO2 exposures since the beginning of ISS operations has been compared to the 
incidence of crew symptoms reported in private medical conferences. We have used this database in an 
attempt to establish an association between the CO2 levels and the risk of crew symptoms.  
 
This comparison will answer the question of the level needed to protect the crew from unacceptable risk of 
acute effects. As for the second part of the question, operation of the ISS’s regenerable CO2 removal 
capability reduces the limited life of constituent parts. It also consumes limited electrical power and thermal 
control resources.  Operation of consumable CO2 removal capability (LiOH) uses finite consumable 
materials, which must be replenished in the long term.  Therefore, increased CO2 removal means increased 
resource use, with increased logistical capability to maintain necessary resources on board ISS.  We must 
strike a balance between sufficiently low CO2 levels to maintain crew health and CO2 levels which are 
operationally feasible for the ISS program.  
Nomenclature 
BMD =  Benchmark Dose 
BMDL = Lower 95% confidence on BMD 
CDRA = Carbon Dioxide Removal Assembly 
CPT = Continuous Performance Task 
CTB = Cargo Transfer Bag 
DAB = Desiccant Absorbent Bed 
ISS = International Space Station 
MCA = Major Constituent Analyzer 
ORU = Orbital Replacement Units 
PMC = Private Medical Conference 
USOS =  United States Operating Segment 
I. Introduction 
EMOVAL of carbon dioxide (CO2) from the atmosphere of any human-occupied spacecraft is an important 
problem.  Humans generate CO2 at a rate of 0.9-1.2 kg per day1 and may experience subtle acute symptoms at 
concentrations somewhat below 1.0% (7.6 mmHg).2,3 It is not feasible to achieve earth-normal levels of about 0.3 
mmHg in spacecraft. The key question is what acute symptoms could arise as a result of CO2 exposure that could 
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affect crew performance and well being, and at what exposure levels (concentration and time of exposure) do these 
effects occur? We will focus our attention on acute exposure histories of 7 days or less with the understanding that 
prolonged exposures to moderate levels of CO2 could cause lasting adverse effects. The issue is confounded by the 
possibility that the fluid shifts present in astronauts increase susceptibility to CO2-induced effects and this is not easy 
to model in ground-based studies. Furthermore, there are likely to be substantial inter-individual differences in 
susceptibility to CO2 exposures, so that concentrations transparent to some crewmembers may have a distinct effect 
on other crewmembers. Thus, we are faced with the necessity of using in-flight data from a heterogeneous 
population in an attempt to discern if subtle adverse effects can be associated with increases in CO2 levels. If such an 
association can be found, then we may be able to develop a dose-response curve from which we can estimate the 
level of control we must exert over CO2 exposures. 
 Assuming we can estimate risks, at least for some effects, we may then ask what resources must be consumed in 
order to achieve a specific level of risk. This is an important question for near-earth vehicles such as the 
International Space Station (ISS) because of the cost of supplying resources will increase as we attempt to manage 
CO2 concentrations to lower levels. Our goal in this paper is to illustrate how to estimate the resource cost to achieve 
a targeted level of control of CO2 exposure. For example, how many more resources will be required to manage CO2 
levels to 2 mmHg than 3 mmHg, or 4 mmHg? We can also estimate the risk of adverse effects if CO2 levels cannot 
be well controlled because of hardware failure.  
 If wise CO2 management aboard the ISS is important, then it will be absolutely critical for exploration class 
missions where resupply is not possible. Undertaking such long-duration missions will be challenging under any 
circumstances; however, we cannot allow accumulation of CO2 to affect crew behavior and performance. Yet the 
cost of over managing CO2 will be tremendous in an exploration vehicle. Thus, we must have a reasonably precise 
estimate of the effects of CO2 on the crewmembers that will live in such a vehicle. This means that we must consider 
screening for susceptibility to CO2 in the crew selection process. 
 
II. Approach 
A.  Record of CO2 Concentrations aboard the ISS 
 
 The major constituent analyzer (MCA) provides data that can be used to estimate CO2 levels and these levels are 
available from the earliest days of ISS operations. Data were available to us as 10-minute average concentrations. 
Measurements are taken from selected modules and generally the distribution of CO2 concentrations is fairly 
uniform. However, at times and in certain locations CO2 levels can go well above the levels measured by the MCA. 
If crewmembers are working in a location with suboptimal air flow, then local concentrations at the breathing zone 
can be somewhat higher than the module average. Thus, the MCA data are not perfect measurements of crew 
exposure, but they are reasonably representative when averaged over a day or week.  
 The range of concentrations found in ISS modules sometimes averages less than 2 mmHg and at other times it 
exceeds 5 mmHg (see figure 1a and b). 
       
 
 
 
 
 
B. Data Reported on Headaches 
 
Figure 1a. One day of CO2 concentrations during a 
time of relatively low CO2 concentrations aboard the 
ISS.  
 
Figure 1b. One day of CO2 concentrations during a time 
of relatively high CO2 concentrations aboard the ISS 
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 Discovering and capturing subtle effects of any exposure challenges investigators even in well-controlled 
studies. During operations of the ISS, crewmembers are obviously exposed to CO2 concentrations well above earth 
normal. In addition, the stress and loss of gravity cause a number of adverse effects on crewmembers throughout the 
mission. Most of the acute effects unassociated with CO2 disappear within a week of experiencing microgravity, so 
we excluded adverse effects reported by a crewmember within a week of arrival on orbit. We searched for effects 
that would be relatively specifically reported in private medical conferences (PMCs) and came up with two: visual 
effects and headaches. Only headaches were reported often enough to be a useful index of an effect that could be 
associated with CO2 exposures, and these have been associated with high CO2 exposures in ground-based studies .4  
 We compared the frequency of reported headaches to no reported headache during PMCs with the average CO2 
concentrations during the period 7-days before each report and during 24 hours before the report. We also compared 
the highest CO2 concentrations in the previous 24 hours to the incidence of PMC-reported headaches. We blocked 
the data in groups as follows: <2 mmHg, 2-3 mmHg, 3-4 mmHg, and >4 mmHg. 
 
C. Data Reported on Behavioral Effects 
 
 The WinSCAT system has been used for several years aboard the ISS to assess behavioral parameters.5 Some 
very limited ground-based studies have shown transient, subtle visual effects from CO2 at concentrations as low as 5 
mmHg 2,3. We wanted to use WinSCAT test data, some of which depends on visual integrity, to see if there was an 
association between behavioral performance and higher CO2 levels. Environmental factors are known to affect 
WinSCAT results.5,6 We used a two tier approach in comparing behavioral data to CO2 levels as follows: 1) total 
raw and differential (preflight vs. in flight = Δ) WinSCAT scores, and 2) four throughput sub-scores as raw and 
differential scores. The four sub-scores were as follows: Mathematical Processing (twenty 3 item 
addition/subtraction problems), Continuous Performance Task (CPT, 160 one second back numerical memory task), 
Code Substitution Delayed Recognition (eighteen delayed memory items after 72 stimulus items) and Match to 
Sample (twenty block design matching items).  
 We searched for an association between CO2 and behavioral test changes using a scatter gram and linear fit to 
the behavioral scores. We compared 1-day and 1 week average pre-test CO2 levels to the raw and differential scores 
of the composite WinSCAT score and to each of the four sub-test scores.  
 
D. Benchmark Dose Analysis 
 
 The Environmental Protection Agency has developed benchmark dose software (BMD, version 2.1.2) to 
facilitate the estimation of risk based on dose-response data. Typically, one seeks a low response rate or risk to 
protect against a specific adverse effect such as headache or visual disturbance. The usual application is to begin 
with a set of well known exposure levels, and then measure the range of some adverse effect at each exposure level. 
The data we have are not ideal. We have a mean dose (CO2 concentration in each interval) and standard deviation 
and only one response point (the percent of the time of a response reported in a PMC or WinSCAT) for each mean 
concentration. None the less, the curve fitting can be accomplished and can inform us of the concentration where we 
can expect a certain risk of an adverse effect. In addition, the modeling provides an estimate of the 95% lower bound 
on the benchmark dose (BMDL).  
 
E. Estimating Resource Needs 
 
The CO2 scrubbing system for the United States Operating Segment (USOS) consists primarily of the 2 CDRAs.  
CDRA is a swing-bed type CO2 removal system which uses zeolite as an adsorbent material, and evacuates adsorbed 
CO2 to space vacuum.  One CDRA was designed for CO2 removal for 4 crew, plus 1.25 human crew equivalent 
worth of animals, although actual flight data has shown that a single CDRA can sustain <5.3mmHg (10.2 psia) CO2 
partial pressure for up to 9 crewmembers.7 Based on historical flight data, the rule of thumb is 6 crew per CDRA, 
which allows for levels around 4mmHg CO2 partial pressure.  With both CDRAs and Vodzdukh operating, CO2 can 
be brought below 2mmHg (fig 1b), although this is extremely resource intensive. 
 CDRA operation requires electrical power and thermal heat load shedding,  Each CDRA requires approximately 
900W of electrical power and 200-1000W of heat load rejection to the ISS thermal control system.  Because both 
electrical power and thermal load are limited resources on ISS, any resources used by CDRA must be taken from 
other operational systems or scientific payloads.  Therefore, it is important that CDRA only operate as much as is 
necessary for crew comfort and health.   
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 Additionally, each CDRA consists of multiple orbital replacement units (ORUs) which have limited lives.  These 
include the 2 CDRA desiccant adsorbent bed assemblies (DAB), a Blower/Precooler assembly, and 6 individual 
valves.  Each of these components has a limited life after which it must be replaced to maintain CDRA operation, 
most notably the DABs.  Each DAB weighs approximately 90lbs and 5 Cargo Transfer Bags (CTB) equivalent 
volume, one CTB equivalent being a standard of NASA cargo operations equal to approximately 1.6 ft3.  Because of 
this weight and volume, CDRA DABs are highly resource intensive to fly.  CDRA DABs currently have a limited 
life due to internal Zeolite Dust accumulation leading to eventual flow occlusion.7 The exact life varies between 
individual units, but averages less than 2 years of nominal operations before the DAB needs replacement.  Current 
re-designs are in the work to mitigate this problem,8 but until this problem is solved the CDRA must be used 
judiciously to preserve DAB life.  
 
 
III. Results and Discussion 
A.  Benchmarking CO2 Concentrations and Incidence of Headaches 
 
 An example of the benchmark dose 
application to the association we found 
between PMC-reported headaches and 
24-hour average CO2 levels (dose) 
within the four ranges is shown in figure 
2. Since percentages are not normally 
distributed, the percent response levels 
were transformed to a normal 
distribution using arcsine of the square 
root of the decimal percentage such that 
a mean response of 0.1 is equivalent to a 
risk of approximately 1% that a 
headache will be reported during a given 
PMC. In this example the maximum 
likelihood value (BMD) is 2.3 mmHg 
and the lower 95% confidence interval 
(BMDL) is about 1.4 mmHg. Two other 
models (power and polynomial) gave 
similar BMDs to the example shown 
here, but their BMDLs were much lower.  
 A mean response on the transformed 
scale of 0.2 is approximately a probability 
of 4% that a headache will be reported during a PMC. Additional modeling of the prevalence of headaches and CO2 
exposures are expected when further data on headaches are obtained. For example, the above analysis is weakened 
by the fact that there were only 20 PMCs that had a 24-hour average CO2 value below 2 mmHg. Thus the data point 
at an average of 1.6 mmHg in figure 2 is not firmly established because with only 20 observations we have a low 
probability of detecting even a single headache if the true incidence is below 5%. Since we are operating the ISS at 
lower CO2 levels than in previous years, it is likely that we will accumulate experience in the sub 2 mmHg range. 
 We are also seeking additional insight into the dose-response relationship between the incidence of headaches 
and exposure to CO2 by searching for reports of headaches outside the domain of PMCs. We are looking for specific 
astronauts that might be particularly sensitive to CO2. The reality is that over more than a decade of ISS operations 
the dozen headaches reported during PMCs is not a serious health concern, although the astronaut’s ability to 
perform complex tasks would be compromised with anything more than a very mild headache. It is also possible that 
astronauts simply take an analgesic to relieve mild headaches and never report these during a PMC.  
 
B. Associations in Behavioral Data 
 
 None of the behavioral parameters yielded a convincing response to higher CO2 levels, although the ΔCPT 
scores at first seemed promising when we used only the changes above the threshold value for significant change 
Figure 2. Benchmark-dose analysis of average CO2 dose compared 
to statistically-transformed percentage of headaches as reported in 
PMCs. A linear model was used. 
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(figure 3). Initially, we examined only the changes in score above the clinically-relevant threshold of 8 units; 
however, further discussion and a statistical consultation suggested that we should look at all scores of those 
astronauts who showed any scores above the clinically-relevant threshold. Once we did that (figure 4) it was 
apparent that we could not associate group changes in ΔCPT with increased exposures to CO2 over the preceding 24 
hours. Furthermore, we could not identify individual astronauts who seemed to be consistently responsive to higher 
CO2 levels. Comparison of these figures illustrates the challenge of finding meaningful associations between 
variables when many confounding factors are involved.  
 
  
 
 
 
 
C. Estimates of Resource Needs 
 
 Operating one CDRA combined with the Russian Vozdukh system currently results in ~3 mmHg pp CO2 
average, depending on current crew activity.  This is typically the assumed nominal operating posture in the time 
between docked Space Shuttle missions, when ISS crew consists of 6 individuals.  The second CDRA can be 
activated temporarily for anticipated times of high CO2 loading such as docked shuttle missions.  Given current 
operational capability, maintaining CO2 below 3 for extended periods of time for 6 crewmembers would require two 
operating CDRAs. The power, heat shedding, and up-mass demands may be too high for practical operations. 
 As stated in section II E, the CDRA is currently limited by a DAB life of <2 years, and DAB replacements are 
highly resource intensive.  The DAB fleet currently consists of 6 cores, with 2 cores required per operating CDRA.  
Therefore having two CDRAs in operational condition on board ISS requires 4 DAB cores be on board at any given 
time.  The DABs are currently in their 3rd design generation, with a 4th generation in process.  The 2 DAB cores 
remaining on the ground will have 4th generation modifications applied, at which time they will be flown and 
installed into one of the CDRAs.  Ideally, the design changes made to the 4th generation DABs will allow a much 
longer operational life than the current <2 years, but that remains to be verified in operation.  Once two of the 3rd 
generation DABs have  been replaced by 4th generation DABs, they can theoretically be returned to the ground and 
Figure 3. Initial look at the ΔCPT score vs. 
CO2 concentrations for nine astronauts; 
each one is shown in different colors. The 
line suggests the possibility of an 
association of increased ΔCPT scores with 
increasing CO2 concentration. 
Figure 4. When all ΔCPT scores are 
considered, including those below the 
clinically-relevant threshold of 8, there is 
clearly no association demonstrated 
between the score and CO2 exposures 
ΔCPT 
 ΔCPT 
CO2 mmHg 
CO2 mmHg 
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rebuilt as a second set of 4th generation DABs.  However, at the current time the Space Shuttle is the only vehicle 
with sufficient cargo capability to return hardware as large as a CDRA DAB.  Once the Space Shuttle undergoes 
planned retirement in 2011, future CDRA DAB design iteration will be dependent on as-yet unidentified spaceflight 
capability.    
 Limited 3rd generation DAB life, combined with uncertain future capability to return hardware from ISS, means 
that operating 2 CDRAs simultaneously for extended periods would have high risk implications. 
 
 
IV. Conclusions 
 We are in the middle stage of searching for subtle adverse effects of CO2 exposure during stays aboard the 
ISS. The data we have at this point suggests that maintaining a CO2 level of 2-2.5 mmHg will result in a 1% risk that 
headaches could be reported during a PMC and a 4% risk if kept at ~4 mmHg CO2. Although lower CO2 is always 
considered better, operational limits below 3 mmHg CO2 are not practical from a hardware standpoint. 
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